Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Feb 24 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-feb-24-2023-3

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 24, 2023, titled "Zydus receivesfinal approval from the USFDA for Pitavastatin Tablets, 1 mg, 2 mg, and 4 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases